Pendium

Step 1 of 9

Aveeno owns the sensitive skin conversation in AI, but competitors are winning on clinical claims.

The brand is a category leader. The challenge now is defending that lead against clinical-first brands that are currently dominating newer AI training sets.

Aveeno's baseline score
84/100
Excellent

Aveeno enjoys exceptional AI visibility, particularly in the US market, due to its deep historical footprint in editorial and clinical datasets. It is the canonical recommendation for oat-based treatments, though it faces increasing competition from CeraVe in 'dermatologist' specific queries.

What we see
  • Aveeno is mentioned in nearly every 'best lotion for eczema' prompt across all platforms.
  • The brand has a significant 'share of voice' on Reddit and health blogs, which Gemini and ChatGPT heavily weight.
  • Competitors like CeraVe are currently winning the 'dermatologist recommended' specific phrasing, while Aveeno wins the 'gentle and natural' phrasing.
  • Hair care visibility is significantly lower than body and facial skincare visibility.
  • The Baby category is a fortress for the brand, frequently appearing as the #1 or #2 recommendation for infant skin issues.
Business goals Aveeno is likely trying to hit
  • Maintain dominance in the dermatologist-recommended drugstore category
  • Expand market share in the premium therapeutic scalp and hair care segment
  • Strengthen brand association with 'natural' and 'science-backed' sensitive skin care
  • Defend position against clinical-first brands like CeraVe in AI-driven recommendations